Immunotherapy / Autologous cellular immunotherapyFDA-approvedFirst-line
Sipuleucel-T
Generic name: sipuleucel-T
How it works
Trains the immune system to recognize and attack prostate cancer cells.
Cancer types
Prostate Cancer— All patients
Efficacy
Sipuleucel-T has been shown to improve overall survival in patients with metastatic castration-resistant prostate cancer.
Side effects
Mild
Most people tolerate this treatment well. Side effects are generally manageable and do not require stopping treatment.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Combining Sipuleucel-T with Other Treatments for Prostate Cancer | Prostate Cancer | review | — | Source → |
| Hidden Heart Risks in Prostate Cancer Treatment | Prostate Cancer | observational | — | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.